Search results
Results from the WOW.Com Content Network
It would be acceptable to consider that raw materials used to manufacture pharmaceutical products can vary in their attributes e.g. moisture content, crystal structure etc. It would also be acceptable to consider that manufacturing equipment does not always operate in exactly the same fashion due to the inherent tolerance of the equipment and ...
The material cost of a chemical process is the sum of the costs of all raw materials, intermediates, reagents, solvents, and catalysts procured from external vendors. Material costs may influence the selection of one synthetic route over another or the decision to outsource production of an intermediate.
Process engineering activities can be divided into the following disciplines: [7] Process design: synthesis of energy recovery networks, synthesis of distillation systems (), synthesis of reactor networks, hierarchical decomposition flowsheets, superstructure optimization, design multiproduct batch plants, design of the production reactors for the production of plutonium, design of nuclear ...
Pharmaceuticals and foodstuff ingredients are the main industries in which micronization is utilized. Particles with reduced diameters have higher dissolution rates, which increases efficacy. [ 9 ] Progesterone , for example, can be micronized by making very tiny crystals of the progesterone. [ 14 ]
A raw material going into a chemical process or plant as input to be converted into a product is commonly called a feedstock, or simply feed. In addition to feedstocks for the plant, as a whole, an input stream of material to be processed in a particular unit can similarly be considered feed for that unit.
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. [1]
DGDA regulates all activities related to import and export of raw materials, packaging materials, production, sale, pricing, licensing, registration of all kinds of medicine including those of Ayurvedic, Unani, herbal and homeopathic systems. [2] The Pharmacy Council of Bangladesh(PCB) was established under the Pharmacy Ordinance Act in 1976.
In 1995, [5] Granules became a public company, after having initial public offerings on the Bombay and Hyderabad Stock Exchanges. [7] In 2013, Granules India acquired Auctus Pharma for Rs 120 crore. [8] In 2016, Granules India commissioned a new state of the art manufacturing unit that hosts facilities for Oncology and High Potent APIs.